Nine unfavorable prognosis-associated and six favorable prognosis-associated proteins were detected in our proteome data, in which MDK (Supplementary Fig. 1c) was the only protein associated with unfavorable prognosis in glioma patients (Fig. 1c). This evidence concerns the gene MDK and central nervous system cancer.